Open Access<p>Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial</p>
Author(s) -
G. Macchia,
Savino Cilla,
Milly Buwenge,
Alice Zamagni,
I. Ammendolia,
Claudio Zamagni,
G.P. Frezza,
Vincenzo Valentini,
Francesco Deodato,
Alessio Giuseppe Morganti
Publication year - 2020
Publication title -
breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.19
H-Index - 27
ISSN - 1179-1314
DOI - 10.2147/bctt.s261587
Subject(s) - medicine , radiation therapy , concomitant , breast cancer , tolerability , surgery , urology , hormonal therapy , oncology , cancer , adverse effect
A concomitant boost (CB) in patients treated with postoperative radiotherapy after conservative surgery of invasive breast cancer (BC) has been suggested for treatment time reduction and therapy intensification. The aim of this analysis was to assess long-term tolerability of a CB in patients treated with postoperative intensity Modulated Accelerated RAdiotherapy (MARA).